Showing results (551-560 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 8, 2020
The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosisCecilia Smith Simonsen, Heidi Øyen Flemmen, Trine Lauritzen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 22, 2021
Prioritizing the healthcare access concerns of Canadians with MSJulie Pétrin, Mary Ann McColl, Catherine Donnelly, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 27, 2019
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosisMonica Margoni, Francesca Rinaldi, Silvia Miante, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2020
Fatal COVID-19 in an MS patient on natalizumab: A case reportKathryn Rimmer, Rebecca Farber, Kiran Thakur, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 26, 2019
Effect of different doses of gadolinium contrast agent on clinical outcomes in MSNathalie Ackermans, Carolyn Taylor, Roger Tam, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 24, 2018
The topographical model of MS: Empirical evaluation of the recapitulation hypothesisBenjamin M Laitman, Karin Cook, Madhuri Fletcher, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 8, 2019
Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical settingLaura E Baldassari, Jenny Feng, Gabrielle Macaron, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 1, 2021
Remote administration of the symbol digit modalities test to individuals with multiple sclerosis is reliable: A short reportTehila Eilam-Stock, Michael T Shaw, Kathleen Sherman, et al.
Pageof 61